Exploiting science for engineering: BRCA2 targeted therapies

Similar documents
The Need for a PARP in vivo Pharmacodynamic Assay

Recombinant DNA & Genetic Engineering. Tools for Genetic Manipulation

Translating DNA repair pathways into therapeutic targets: beyond the BRCA1/2 and PARP inhibitor saga. Jorge S Reis-Filho, MD PhD FRCPath

restriction enzymes 350 Home R. Ward: Spring 2001

DNA ligase. ATP (or NAD+)

PARP inhibition basic science and clinical challenge. Thomas Helleday, PhD

CCR Biology - Chapter 9 Practice Test - Summer 2012

Recombinant DNA and Biotechnology

RevertAid Premium First Strand cdna Synthesis Kit

HCS Exercise 1 Dr. Jones Spring Recombinant DNA (Molecular Cloning) exercise:

Recombinant DNA Technology

Hereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

ab Hi-Fi cdna Synthesis Kit

CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA

Molecular Biology Techniques: A Classroom Laboratory Manual THIRD EDITION

A and B are not absolutely linked. They could be far enough apart on the chromosome that they assort independently.

Notch 1 -dependent regulation of cell fate in colorectal cancer

Lecture 13: DNA Technology. DNA Sequencing. DNA Sequencing Genetic Markers - RFLPs polymerase chain reaction (PCR) products of biotechnology

Cloning GFP into Mammalian cells

Recombinant DNA Unit Exam

Gene Cloning. Reference. T.A. Brown, Gene Cloning, Chapman and Hall. S.B. Primrose, Molecular Biotechnology, Blackwell

4. DNA replication Pages: Difficulty: 2 Ans: C Which one of the following statements about enzymes that interact with DNA is true?

Improved methods for site-directed mutagenesis using Gibson Assembly TM Master Mix

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

PCR was carried out in a reaction volume of 20 µl using the ABI AmpliTaq GOLD kit (ABI,

HighPure Maxi Plasmid Kit

Genome Editing TOOLS TO SUPPORT CRISPR/CAS9 APPLICATIONS

RIBOPROTECT. RNase Inhibitor RT33-020, RT33-100

New Directions in Treatment of Ovarian Cancer. Amit M. Oza Princess Margaret Hospital University of Toronto

BacReady TM Multiplex PCR System

Bacterial Transformation and Plasmid Purification. Chapter 5: Background

Cloning Blunt-End Pfu DNA Polymerase- Generated PCR Fragments into pgem -T Vector Systems

Genetic Engineering and Biotechnology

Chapter 6 DNA Replication

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

Genetic Technology. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.

Troubleshooting the Single-step PCR Site-directed Mutagenesis Procedure Intended to Create a Non-functional rop Gene in the pbr322 Plasmid

DNA Fingerprinting. Unless they are identical twins, individuals have unique DNA

First Strand cdna Synthesis

Chromatin Immunoprecipitation

Investigating a Eukaryotic Genome: Cloning and Sequencing a Fragment of Yeast DNA

Expression and Purification of Recombinant Protein in bacteria and Yeast. Presented By: Puspa pandey, Mohit sachdeva & Ming yu

HT F Homogeneous PARP Inhibition Assay Kit. HT F Homogeneous PARP Inhibition Assay Kit. 96 Tests. Table of Contents.

Analysis of the DNA Methylation Patterns at the BRCA1 CpG Island

Fighting the Battles: Conducting a Clinical Assay

Molecular and Cell Biology Laboratory (BIOL-UA 223) Instructor: Ignatius Tan Phone: Office: 764 Brown

TransformAid Bacterial Transformation Kit

Green Fluorescent Protein (GFP): Genetic Transformation, Synthesis and Purification of the Recombinant Protein

PyroPhage 3173 DNA Polymerase, Exonuclease Minus (Exo-)

Genomic DNA Clean & Concentrator Catalog Nos. D4010 & D4011

GENE CLONING AND RECOMBINANT DNA TECHNOLOGY

European Medicines Agency

Enhanced cytotoxicity of PARP inhibition in Mantle Cell Lymphoma harboring mutations in both ATM and p53

Design of conditional gene targeting vectors - a recombineering approach

Genetics Test Biology I

PARP Inhibitors in Lung Cancer. Primo N. Lara, Jr., MD Professor of Medicine UC Davis Comprehensive Cancer Center

Bio 102 Practice Problems Recombinant DNA and Biotechnology

Bacterial Transformation with Green Fluorescent Protein. Table of Contents Fall 2012

mirnaselect pep-mir Cloning and Expression Vector

RT-PCR: Two-Step Protocol

Lab 10: Bacterial Transformation, part 2, DNA plasmid preps, Determining DNA Concentration and Purity

Transformation Protocol

ptune Inducible Vector

Lecture 1 MODULE 3 GENE EXPRESSION AND REGULATION OF GENE EXPRESSION. Professor Bharat Patel Office: Science 2, b.patel@griffith.edu.

Targeted therapies in hereditary cancer with PARP-inhibitors: a new biological approach.

User Manual. CelluLyser Lysis and cdna Synthesis Kit. Version 1.4 Oct 2012 From cells to cdna in one tube

Real-time monitoring of rolling circle amplification using aggregation-induced emission: applications for biological detection

AP BIOLOGY 2007 SCORING GUIDELINES

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

BioS 323: Molecular Biology Laboratory. Fall Semester CRN3636 Tuesday & Thursday 2PM to 5PM 3068 SEL

Wide range of high-quality enzymes and proteins for molecular biology

ExpressArt Bacterial H-TR cdna synthesis kit. With extreme selectivity against rrnas

Biotechnology: DNA Technology & Genomics

DNA Replication in Prokaryotes

1/12 Dideoxy DNA Sequencing

Application Guide... 2

GENETICS (BIO240) Syllabus

1) Aug 2005 In Vitro Chromosomal Aberration Study Cytotoxicity (File: TS39) Conclusion No cytotoxicity can be detected at concentrations up to 100%.

PARP Inhibition: A Method of Treating and Preventing Certain Cancers Abstract Introduction Methods Figure1 Homologous recombination repair:

qstar mirna qpcr Detection System

Cyclin-Dependent Kinases and CDC7 as Therapeutic Targets

The Techniques of Molecular Biology: Forensic DNA Fingerprinting

Biomarkers of PARP inhibitor sensitivity

Basic attributes of genetic processes (replication, transcription, translation)

Compiled and/or written by Amy B. Vento and David R. Gillum

PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?

QUANTITATIVE RT-PCR. A = B (1+e) n. A=amplified products, B=input templates, n=cycle number, and e=amplification efficiency.

RT rxns. RT rxns TRANSCRIPTME Enzyme Mix (1) 40 µl 2 x 50 µl 5 x 40 µl

DNA Technology Mapping a plasmid digesting How do restriction enzymes work?

MagExtractor -Genome-

IMBB Genomic DNA purifica8on

Introduction to cloning

Basic Concepts Recombinant DNA Use with Chapter 13, Section 13.2

DNA Isolation Kit for Cells and Tissues

PARP inhibitors and TEMOZOLAMIDE in BRAIN TUMORS. Idoia Morilla Ruiz

Appendix C DNA Replication & Mitosis

DNA Scissors: Introduction to Restriction Enzymes

2. The number of different kinds of nucleotides present in any DNA molecule is A) four B) six C) two D) three

Transcription:

20.109 MOD1 DNA ENGINEERING Fall 2010 Exploiting science for engineering: BRCA2 targeted therapies Orsi Kiraly Engelward lab

Homologous recombination is important No HR chromosomal aberrations cell death Sonoda 1998 Faulty HR normal Rad51-/- no HR premature aging cancer

Homologous recombination is critical for repair of broken replication forks

Homologous recombination is critical for repair of broken replication forks Grigorova 2004 NHEJ BRCA2-/-

Understanding biology leads to new technologies h2p://wyss.harvard.edu h2p://www.nmri.go.jp

Recombinant DNA toolbox is from nature Plasmids Radloff 1967 PNAS www.promega.com Heat stable DNA polymerases Photo: Agriculture and Agri-Food, Canada http://users.ugent.be/~avierstr/principles/pcr.html Restriction endonucleases Lydia Dorner and Ira Schildkraut, New England Biolabs www.fermentas.com

Understanding science leads to new technologies: BRCA2 targeted therapy PARP Inhibitors Represent New Direction in Cancer Treatment Roitt 1956

Metabolism is suppressed by alkylating agent In tumor cells no treatment CO 2 from catabolism alkylating agent http://www.dugway.army.mil Roitt 1956 Time (min)

NAD levels are lowered by alkylating agent In tumor cells no treatment CO 2 from catabolism Alkylating agent + NAD alkylating agent Roitt 1956 Time (min)

NAD levels are lowered by alkylating agent In slime mold NAD Less NAD is made? Why? No Time (hours) More NAD is degraded? No Used up to build something?? Yes! PARP activity up 200% Poly(ADP-ribose) polymerase (PARP) Time (hours) Whish 1975

NAD is a precursor for poly(adp-ribose) chromatin

What is the role of poly(adp-ribosylation)? Inhibit it, see what happens: % Surviving cells control PARP inhibition Alkylating agent Inhibition of PARP affects survival after treatment with DNA damaging agent PARP has a role in DNA repair Durkacz 1980 Mouse leukemia cells

What is the role of poly(adp-ribosylation)? Inhibit it, see what happens: More HR More single strand breaks Waldman 1991 Boulton 1999 In the absence of PARP, HR is needed to fix broken fork HR What about cancer cells that can t do HR?

What about cancer cells that can t do HR? Potentially TOXIC no PARP NHEJ BRCA2-/-

BRCA2 null cells are extremely sensitive to PARP inhibitors In cells PARP inhibitor Surviving fraction BRCA2 null wt wild type BRCA2 null Bryant 2005 PARP inhibitor (µm)

BRCA2 null cells are extremely sensitive to PARP inhibitors In mice wt Frequency of tumor formation BRCA2 null wt PARP inhibitor BRCA2 null Farmer 2005 Time (days) TARGETED to tumor by virtue of the tumor s own mutation!

advanced ovarian cancer

Synthetic lethality and an assay to find it Each decrease expression of a single gene

Lecture 1: Lecture 2: Intro to importance of HR How HR works Lecture 3: Why understanding mamers: BRCA2 and HR Lecture 4: Lecture 5: Lecture 6: Lecture 7: Lecture 8: ExploiRng scienrfic understanding for engineering: BRCA2 targeted therapies Measuring HR in genotoxicity tesrng, using HR in genome engineering of mice Journal arrcle discussion StaRsRcs Flow Cytometry: How it works and how to do it

Mod 1: DNA Engineering Engineering in vitro recombinaron assay Day 4

A Plasmid-Based Assay for Homologous Recombination in Mammalian Cells Δ5 + lipofect 48 hours Δ3

1 PCR X E 2 Purif. X E Digest 2 X E Gel 3 Purif. X E X E Gel 3 Anal. X E X E Plan Lig. 3 X E Ligate 4 4 Transform E. coli E. coli E. coli E. coli

Ligase from T4 bacteriophage is used in recombinant DNA technology textbooko?acteriology.net http://www.biochem.umd.edu

Your ligation reaction Ligase ATP Buffer Water, salts, buffer system DTT Ligase has NO activity w/o DTT DTT is unstable Make single use aliquots Vortex to suspend SMELL Vector Insert How much? In what ratio?

Your ligation reaction Vector Insert How much? In what ratio? Reaction conditions Optimal temperature for T4 ligase is 25 C

Your ligation reaction: possible outcomes nothing Population of different products Need to separate and amplify individual products to analyze and select correct one

Transforming bacteria with ligation reaction MIX SHOCK PLASMID TAKEN UP electric (10-20 kv/cm) temperature (42 C ice) RECOVER grow in rich media SEPARATE SELECT AMPLIFY separate by spreading

Proceed to grow up individual colonies and analyze ligation products SEPARATE SELECT AMPLIFY GROW UP INDIVIDUAL COLONIES ISOLATE PLASMID DNA ANALYZE